Leveljump Healthcare Corp. (JMPHF)
| Previous Close | 0.0583 |
| Open | 0.0583 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0583 - 0.0583 |
| 52 Week Range | 0.0210 - 0.1558 |
| Volume | |
| Avg. Volume | 609 |
| Market Cap | 5.625M |
| Beta (5Y Monthly) | 2.23 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings Date | Apr 30, 2024 - May 06, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NewsfileLevelJump Announces Acquisition of Pre-1954 Pharmacy Charter
Toronto, Ontario--(Newsfile Corp. - April 26, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTC Pink: JMPHF) (FSE: 75J) ("LevelJump" or the "Company"), a Canadian leader in B2B telehealth solutions, is pleased to announce that it has entered an agreement to acquire a pre-1954 pharmacy charter corporation ("Pharmacy License").The Company has agreed to purchase the Pharmacy License for $1,900,000, to be paid as $1,800,000 in cash and 100,000 shares of JUMP preferred shares. To date ...
NewsfileLevelJump Announces MCTO Application Denied
Toronto, Ontario--(Newsfile Corp. - April 26, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTC Pink: JMPHF) (FSE: 75J) ("LevelJump" or the "Company") announces that its application for a management cease trade order ("MCTO") under National Policy 12-203 Management Cease Trade Orders ("NP 12-203") has been denied by the Ontario Securities Commission (the "OSC") (see the Company's news release dated April 15, 2024).As such, it is anticipated that a Failure to File Cease Trade Order (an "FFCTO"
NewsfileLevelJump Announces That It Will Be Delayed in Filing Year-End Reporting Documents
Toronto, Ontario--(Newsfile Corp. - April 15, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") announces today that it anticipates the filing of its annual financial statements, management's discussion and analysis and related officer certifications for the financial year ended December 31, 2023 (collectively, the "Annual Filings") will be delayed beyond the required filing deadline under Parts 4 and 5 of National Instrument 51-102 - Continuous Disclosure Obligation
